Percutaneous transluminal dilatation and recanalization in the treatment of peripheral vascular disease.

Publisher Website
Google Scholar
Abstract
Successful transluminal angioplasties (94) were followed up for as long as 15 mo., during which time 15 failures occurred. Life-table analysis of this series gave a cumulative patency rate of 64%. The patency rate of 70% for iliac lesions compared to 50% for the femoral-popliteal group suggests that the former are likely to have a better long-term prognosis. In selected cases transluminal angioplasty is a viable alternative to surgery that should be available to patient and physician.

This publication has 2 references indexed in Scilit: